Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17931 (
galectin-3
)
2,860
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Experiments using live dissociated carotid body (CB) cells for patch clamping, [Ca(++)](i) or other measurements require positive identification of the cell being recorded. At present, cell morphology is usually employed, but several cell types within the carotid body evidence similar morphologic characteristics. Therefore, we sought to develop a method utilizing a vital dye to identify glomus cells before and during experiments that require live cells, such as patch clamp studies. It was previously reported that the binding sites for peanut agglutinin (PNA) were highly expressed by all neuroendocrine-derivatives of the sympathoadrenal neural crest, including glomus cells, small, intensely fluorescent cells, PC-12 cells, and adrenal chromaffin cells in situ (katz et al. 1995). By utilizing the binding characteristics of
galactose-specific lectin
peanut agglutinin (PNA) on the outer cell membrane, we tested the possibility that the fluoresceinated PNA may preferentially bind to CB glomus cells. The results to date show: (1)
Rhodamine
tagged PNA (Rhod-PNA) binds to the live dissociated glomus cells in less than one hour incubation and can be visualized in superfused cells; (2) Rhod-PNA labeled cells are perfectly matched with tyrosine hydroxylase (TH) positive glomus cells; (3) Rhod-PNA did not interfere with Fura-2 for Ca(++) imaging; (4) Rhod-PNA bound to glomus cells in [Ca(++)](i) studies does not affect O(2) response of glomus cells. Thus fluoresceinated PNA may be a useful marker for live CB glomus studies, without adversely affecting their physiologic response.
...
PMID:Fluoresceinated peanut agglutinin (PNA) is a marker for live O(2) sensing glomus cells in rat carotid body. 1953 80
Dual clickable nanospheres (DCNSs) were synthesized in one step using an efficient approach of ultrasonic-assisted azide-alkyne click polymerization, avoiding the need of surfactants. This novel approach presents a direct clickable monomer-to-nanosphere synthesis. Field emission scanning electron microscopy (FESEM), Fourier transform infrared spectroscopy (FTIR), and dynamic laser scattering (DLS) were used to characterize the synthesized DCNSs. Numerous terminal alkynyl and azide groups on the surface of DCNSs facilitate effective conjugation of multiple molecules or ligands onto a single nanocarrier platform under mild conditions. To exemplify the potential of DCNSs in biological applications, (1) multivalent glyconanoparticles (GNPs) were prepared by clicking DCNSs with azide-functionalized and alkyne-functionalized lactose sequentially for the determination of carbohydrate-galectin interactions with quartz crystal microbalance (QCM) biosensor. Using protein chip (purified
galectin-3
coated on chip) and cell chip (Jurkat cells immobilized on chip), the QCM sensorgrams showed excellent binding activity of GNPs for galectins; (2) fluorescent GNPs were prepared by clicking DCNSs with azide-functionalized
Rhodamine B
and alkyne-functionalized lactose sequentially in order to target galectin, which is overexpressed on the surface of Jurkat cells. The fluorescent images obtained clearly showed the cellular internalization of fluorescent GNPs. This fluorescent probe could be easily adapted to drugs to construct lectin-targeted drug delivery systems. Thus, DCNSs prepared with our method may provide a wide range of potential applications in glycobiology and biomedicine.
...
PMID:One-step synthesis of dual clickable nanospheres via ultrasonic-assisted click polymerization for biological applications. 2521 Oct 60